Induction of parkin expression in the presence of oxidative stress

被引:30
作者
Yang, Yan Xiang
Muqit, Miratul M. K.
Latchman, David S.
机构
[1] Univ London, Inst Child Hlth, Med Mol Biol Unit, London WC1N 1EH, England
[2] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[3] Univ London Birkbeck Coll, London WC1E 7HX, England
关键词
dopamine; 1-methyl-4-phenylpyridinium; parkin; parkin coregulated gene;
D O I
10.1111/j.1460-9568.2006.04998.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Gene mutations have been found in rare familial forms of PD, with mutations in parkin being the most common cause. Oxidative stresses have also been implicated as an important contributing factor in the pathogenesis of PD. Currently, there is accumulating evidence that parkin may play a role in maintaining mitochondrial function and preventing oxidative stress. We demonstrated here that parkin is up-regulated when SH-SY5Y dopaminergic neuroblastoma cells are exposed to the oxidant dopamine.The up-regulation of parkin appeared to be due to transcriptional activation as luciferase assays confirmed that specific parkin promoter constructs could confer enhanced transcriptional activation in response to dopamine. Moreover, this effect was also seen when SH-SY5Y cells were subjected to another oxidative stress, 1-methyl-4-phenylpyridinium. In parallel with these studies, we also observed similar transcriptional activation of the parkin coregulated gene by oxidative stress. This is the first demonstration that parkin expression is up-regulated by oxidative stresses and may suggest that this might be a general neuroprotective response of parkin to oxidative stresses.
引用
收藏
页码:1366 / 1372
页数:7
相关论文
共 46 条
[1]   A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe [J].
Abbas, N ;
Lücking, CB ;
Ricard, S ;
Dürr, A ;
Bonifati, V ;
De Michele, G ;
Bouley, S ;
Vaughan, JR ;
Gasser, T ;
Marconi, R ;
Broussolle, E ;
Brefel-Courbon, C ;
Harhangi, BS ;
Oostra, AB ;
Fabrizio, E ;
Böhme, GA ;
Pradier, L ;
Wood, NW ;
Filla, A ;
Meco, G ;
Denefle, P ;
Agid, Y ;
Brice, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :567-574
[2]   Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? [J].
Barzilai, A ;
Melamed, E ;
Shirvan, A .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 2001, 21 (03) :215-235
[3]  
Berman SB, 1996, J NEUROCHEM, V67, P593
[4]  
Berman SB, 1997, J NEUROCHEM, V69, P1185
[5]  
Betarbet R, 2002, BRAIN PATHOL, V12, P499
[6]   Matlnspector and beyond: promoter analysis based on transcription factor binding sites [J].
Cartharius, K ;
Frech, K ;
Grote, K ;
Klocke, B ;
Haltmeier, M ;
Klingenhoff, A ;
Frisch, M ;
Bayerlein, M ;
Werner, T .
BIOINFORMATICS, 2005, 21 (13) :2933-2942
[7]   S-nitrosylation of Parkin regulates ubiquitination and compromises Parkin's protective function [J].
Chung, KKK ;
Thomas, B ;
Li, XJ ;
Pletnikova, O ;
Troncoso, JC ;
Marsh, L ;
Dawson, VL ;
Dawson, TM .
SCIENCE, 2004, 304 (5675) :1328-1331
[8]   PURIFICATION OF CPG ISLANDS USING A METHYLATED DNA-BINDING COLUMN [J].
CROSS, SH ;
CHARLTON, JA ;
NAN, XS ;
BIRD, AP .
NATURE GENETICS, 1994, 6 (03) :236-244
[9]   Expression profiles of voltage-gated Na+ channel α-subunit genes in rat and human prostate cancer cell lines [J].
Diss, JKJ ;
Archer, SN ;
Hirano, J ;
Fraser, SP ;
Djamgoz, MBA .
PROSTATE, 2001, 48 (03) :165-178
[10]   Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells [J].
Gómez-Santos, C ;
Ferrer, I ;
Santidrián, AF ;
Barrachina, M ;
Gil, J ;
Ambrosio, S .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (03) :341-350